Glycom
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Glycom - overview
Established
2005
Location
-, -, Denmark
Primary Industry
Biotechnology
About
Based in Denmark, Glycom is a biotech company. The company develops novel therapeutics for the treatment of cancer, virus, and bacterial infections.
Current Investors
PreSeed Ventures, Nestle Health Science SA
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Oncology/Cancer Treatment
Website
www.glycom.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.